Current Evidence and Directions for Intermittent Fasting During Cancer Chemotherapy is a research paper published in Advances in Nutrition (2021). On theSindex it has a DataRank of 1.2. It has been cited 37 times, with 35 citing works in its 1-hop citation network.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.546
From this paper's citation signal
Citation Network Contribution
0.620
From 28 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 35 citers.
NIH
Grant: R01CA257807
NIH
Grant: R01CA250390
NIH
Grant: R01CA204808
NIH
Grant: R01DK119783
National Institutes of Health
Grant: 5R01CA250390-02
Mediterranean Diet and Weight Loss: Targeting the Bile Acid/Gut Microbiome Axis to Reduce Colorectal Cancer Risk
National Institutes of Health
Grant: 5R01CA257807-03
Effects of Time-restricted Eating versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers among Adults with Obesity
National Institutes of Health
Grant: 1R01DK119783-01A1
Alternate day fasting combined with exercise for the treatment of NAFLD
National Institutes of Health
Grant: 5R01CA204808-04
Diet modulation of bacterial sulfur & bile acid metabolism and colon cancer risk
FWCI
2.62
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals